Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 14 | 2020 | 250 | 1.130 |
Why?
|
| Brain | 10 | 2020 | 202 | 1.000 |
Why?
|
| DNA Methylation | 7 | 2018 | 44 | 0.670 |
Why?
|
| Genome-Wide Association Study | 7 | 2020 | 46 | 0.420 |
Why?
|
| Cognitive Dysfunction | 4 | 2019 | 165 | 0.400 |
Why?
|
| Cognition Disorders | 3 | 2019 | 175 | 0.360 |
Why?
|
| Aging | 4 | 2018 | 204 | 0.360 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 567 | 0.320 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 46 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 92 | 0.310 |
Why?
|
| Female | 13 | 2020 | 1724 | 0.300 |
Why?
|
| Male | 13 | 2020 | 1860 | 0.300 |
Why?
|
| Humans | 16 | 2020 | 2957 | 0.300 |
Why?
|
| Aged | 11 | 2020 | 956 | 0.300 |
Why?
|
| Cognition | 3 | 2018 | 220 | 0.260 |
Why?
|
| Prefrontal Cortex | 2 | 2017 | 34 | 0.240 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 22 | 0.240 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 23 | 0.240 |
Why?
|
| Hippocampus | 3 | 2019 | 41 | 0.190 |
Why?
|
| Perception | 2 | 2019 | 21 | 0.180 |
Why?
|
| Memory, Episodic | 2 | 2019 | 22 | 0.180 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 16 | 0.170 |
Why?
|
| Gene Expression | 2 | 2017 | 45 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 39 | 0.160 |
Why?
|
| Cohort Studies | 5 | 2020 | 233 | 0.150 |
Why?
|
| Apolipoprotein E4 | 2 | 2017 | 76 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 23 | 0.140 |
Why?
|
| Learning | 1 | 2018 | 20 | 0.140 |
Why?
|
| Cognitive Aging | 1 | 2018 | 27 | 0.130 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 238 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2017 | 59 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 20 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 34 | 0.130 |
Why?
|
| Haplotypes | 1 | 2017 | 9 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2017 | 7 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 7 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 11 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 18 | 0.130 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 260 | 0.130 |
Why?
|
| Neuropathology | 1 | 2017 | 16 | 0.130 |
Why?
|
| Smell | 1 | 2016 | 7 | 0.130 |
Why?
|
| Fetus | 1 | 2016 | 4 | 0.120 |
Why?
|
| Educational Status | 1 | 2016 | 41 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 13 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 43 | 0.120 |
Why?
|
| Antiporters | 1 | 2015 | 4 | 0.110 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2015 | 4 | 0.110 |
Why?
|
| HLA-DRB5 Chains | 1 | 2015 | 4 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 5 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 6 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 13 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 69 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 2 | 2020 | 28 | 0.080 |
Why?
|
| Disease Progression | 2 | 2019 | 99 | 0.070 |
Why?
|
| Sclerosis | 2 | 2019 | 25 | 0.070 |
Why?
|
| Autopsy | 2 | 2019 | 39 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 37 | 0.070 |
Why?
|
| Neurofibrillary Tangles | 2 | 2018 | 24 | 0.070 |
Why?
|
| Genetic Loci | 2 | 2017 | 13 | 0.060 |
Why?
|
| Genotype | 2 | 2017 | 85 | 0.060 |
Why?
|
| Plaque, Amyloid | 2 | 2017 | 18 | 0.060 |
Why?
|
| Middle Aged | 2 | 2017 | 792 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 2 | 0.040 |
Why?
|
| tau Proteins | 1 | 2020 | 18 | 0.040 |
Why?
|
| Fractals | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 8 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 10 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 11 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 5 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 77 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 6 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 8 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2017 | 12 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2017 | 19 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 3 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 7 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 65 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 5 | 0.030 |
Why?
|
| Memory | 1 | 2017 | 48 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2017 | 17 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 44 | 0.030 |
Why?
|
| Depression | 1 | 2017 | 59 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 275 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 6 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 5 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 7 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2016 | 10 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 9 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 187 | 0.030 |
Why?
|
| Chromatin | 1 | 2016 | 5 | 0.030 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2016 | 5 | 0.030 |
Why?
|
| Child | 1 | 2017 | 197 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 203 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 247 | 0.030 |
Why?
|
| United States | 1 | 2016 | 243 | 0.030 |
Why?
|
| Biomarkers | 1 | 2016 | 101 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 8 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 18 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 24 | 0.030 |
Why?
|
| Histones | 1 | 2014 | 3 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2014 | 5 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 794 | 0.030 |
Why?
|
| Mutation | 1 | 2014 | 77 | 0.030 |
Why?
|